A

arista-biotech-pte.-ltd.

browser_icon
Company Domain www.aristabio.com link_icon
lightning_bolt Market Research

Company Research Report: ARISTA Biotech Pte. Ltd.



Company Overview



  • Name: ARISTA Biotech Pte. Ltd.

  • Mission: Creating access to innovative and affordable products and technology, strategic advice, and data analytics in the management of the COVID-19 pandemic.

  • Founded: No information is available.

  • Founders: No information is available.

  • Key People:

  • Dr. Gary Wong - Australia

  • Dr. Nathan Yim - Australia

  • Mr. Gunther Wenzel - Germany

  • Mr. Jimmy Tan - Malaysia

  • Dr. Richard Fong - Thailand

  • Mr. Phil Cody - United Kingdom

  • Headquarters: 190 Middle Road, #16-01 Fortune Centre, 188979, Singapore

  • Number of Employees: No information is available.

  • Revenue: No information is available.

  • Known For: ARISTA is known for its COVID-19 diagnostic test kits and data analytics in managing the pandemic.


Products



ARISTA™ COVID-19 Antigen Rapid Test


  • Description: A rapid test capable of detecting SARS-CoV-2 virus variants, including all major strains and emerging variants like Omicron BA.4 and BA.5.

  • Key Features:

  • Detects variants such as Alpha, Beta, Delta, Epsilon, Gamma, Lambda, and Omicron.

  • High sensitivity similar to that against the original virus.


Viva Life App


  • Description: An application designed for creating verifiable digital health certificates and storing ARISTA diagnostic test records.

  • Key Features:

  • Digital certification and secure record storage.

  • Simplifies access to test information.


Viva Life Enterprise Account


  • Description: A dashboard to manage enterprise safety programs and oversee test statuses.

  • Key Features:

  • Compatible with the Viva Life App to sync test records to organization dashboards.

  • Facilitates management of enterprise safety and testing programs.


Recent Developments



  • Recent Developments:

  • Confirmation of the ARISTA™ COVID-19 Antigen Rapid Test’s sensitivity against the Omicron sub-lineages BA.4 and BA.5.

  • Product authorization for use in South Africa and availability for use in China.

  • Successful registration in Indonesia and Thailand.


  • New Products Launched: No information is available.

  • New Features Added to Existing Products:

  • Continuous updates to detect emerging COVID-19 variants.

  • New Partnerships:

  • Regional distribution partnerships with entities in Australia, Germany, Malaysia, Thailand, and the United Kingdom.


This comprehensive report provides an insight into ARISTA Biotech’s COVID-related products, its strategic role in combating the pandemic, and its global operational presence through strategic partnerships and regional offices.
Browse SuperAGI Directories
agi_contact_icon
People Search
agi_company_icon
Company Search
AGI Platform For Work Accelerate business growth, improve customer experience & dramatically increase productivity with Agentic AI